https://globenewswire.com/news-release/2014/10/26/676503/10104462/en/Novavax-Presents-RSV-F-Protein-Nanoparticle-Vaccine-Clinical-Data-at-the-8th-Vaccine-ISV-Congress-in-Philadelphia-on-Sunday-October-26.html
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment